Chargement en cours...
Effects of bevacizumab in mouse model of endometrial cancer: Defining the molecular basis for resistance
Endometrial cancer is the most frequent gynecologic cancer in women. Long-term outcomes for patients with advanced stage or recurrent disease are poor. Targeted molecular therapy against the vascular endothelial growth factor (VEGF) and its receptors constitute a new therapeutic option for these pat...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3433042/ https://ncbi.nlm.nih.gov/pubmed/21240464 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2011.1147 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|